• Julio Elito Junior, Kyung Koo Han, and Luiz Camano.
• Department of Obstetrics, Escola Paulista de Medicina, Universidade Federal de São Paulo, Rua Maria Carolina 68, Jardim Paulistano, São Paulo (SP), CEP 01445-000, Brazil. elitojr@hotmail.com
• Sao Paulo Med J. 2006 Sep 7; 124 (5): 264266264-6.

Context And ObjectiveAs there is little information about fertility outcomes among women following clinical treatment (methotrexate and expectant management) and surgery (salpingectomy) consequent to ectopic pregnancy, we evaluate the results from hysterosalpingography subsequent to treatment. The objective was to evaluate contralateral tubal patency using hysterosalpingography following surgery and clinical treatment of tubal pregnancy.Design And SettingThis was a prospective study at the Department of Obstetrics of Universidade Federal de São Paulo, a tertiary center.MethodAmong 115 patients who underwent hysterosalpingography following surgery and clinical treatment of tubal pregnancy between April 1994 and February 2002, 30 were treated with a single intramuscular dose of methotrexate (50 mg/m(2)), 50 were followed up expectantly and 35 underwent salpingectomy.ResultsThe patency of the ipsilateral tube was 84% after methotrexate treatment and 78% after expectant management. In addition, contralateral tubal patency was 97% after methotrexate treatment, 92% after expectant management and 83% after salpingectomy. There were no statistically significant differences between the clinical treatment and surgery groups.ConclusionsThe findings from this study suggest similar contralateral tubal patency rates following salpingectomy, methotrexate treatment and expectant management.

27 keywords...

hide…